According to a recent LinkedIn post from Impress, the company’s medical team, led by co‑founder and Chief Orthodontist Khaled Kasem, participated in the 2026 Invisalign EMEA Ortho Summit in Barcelona. The post underscores themes of clinical innovation, digital workflows, and the role of integrated, doctor‑led orthodontics in future care models.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post highlights Align Technology’s digital platform, including iTero digital solutions and ClinCheck treatment planning, as a backbone for connected, end‑to‑end workflows. Impress is portrayed as leveraging this digital infrastructure to support consistency, scalability, and quality control across its network of clinics while enabling personalized treatment.
For investors, the emphasis on digital compatibility and AI‑supported patient monitoring suggests Impress is aligning its operating model with scalable, technology‑driven orthodontic care. If effectively executed, this approach may support margin expansion through operational efficiency, strengthen clinical differentiation, and enhance the company’s competitive position in tech‑enabled orthodontics across EMEA markets.